Biogen Inc (NASDAQ:BIIB)

226.39
Delayed Data
As of Apr 18
 -0.79 / -0.35%
Today’s Change
216.12
Today|||52-Week Range
388.67
-24.77%
Year-to-Date
Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs
Apr 18 / Zacks.com - Paid Partner Content
Biogen (BIIB) Dips More Than Broader Markets: What You Should Know
Apr 15 / Zacks.com - Paid Partner Content
2 Beaten-Down Blue Chips: Are They Buys?
Apr 17 / MotleyFool.com - Paid Partner Content
Better Buy: Gilead Sciences vs. Biogen
Apr 14 / MotleyFool.com - Paid Partner Content
Here's Why Ionis Pharmaceuticals Slumped Today
Apr 17 / MotleyFool.com - Paid Partner Content
Virtu Financial LLC Buys SPDR Gold Trust, DowDuPont Inc, iShares Russell 2000, Sells ...
Apr 12 / GuruFocus News - Paid Partner Content
2 Beaten Down Bluechips: Are They Buys?
Apr 17 / MotleyFool.com - Paid Partner Content
Traynor Capital Management, Inc. Buys iShares National Muni Bond, Constellation Brand...
Apr 12 / GuruFocus News - Paid Partner Content
Biogen (BIIB) Reports Next Week: Wall Street Expects Earnings Growth
Apr 17 / Zacks.com - Paid Partner Content
Biogen (BIIB) Dips More Than Broader Markets: What You Should Know
Apr 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close227.18
Today’s open227.28
Day’s range221.53 - 227.88
Volume2,760,973
Average volume (3 months)1,984,456
Market cap$46.1B
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+81.10%
Earnings growth (this year)+9.95%
Earnings growth (next 5 years)+2.30%
Revenue growth (last year)+9.67%
P/E ratio10.5
Price/Sales5.13
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+0.34+0.11%
EXASExact Sciences Corp+0.40+0.44%
GILDGilead Sciences-0.30-0.47%
BLUEbluebird bio Inc-2.33-1.67%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateApril 24, 2019
EPS forecast (this quarter)$6.84
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts